The CRO was bidding on a rescue program for an enrollment-challenged study and needed to understand what was driving recruitment obstacles in the current mix of sponsor-selected countries.
CASE STUDY | JUN 04, 2026
A Mission to Expand Recruitment Territory
Citeline found most of the sponsor-chosen countries performed ~70% below the enrollment mean. See what other areas for improvement Citeline revealed.
FAQ
What challenge was the CRO trying to solve in this clinical trial?
How did Citeline evaluate which countries were underperforming?
Citeline used Trialtrove+ to benchmark enrollment performance by country and assess metrics such as study activity, retention, and screen failure, comparing sponsor-selected countries against enrollment means and activation timelines.
What was the outcome of the recommendations?
Scenario modeling converged on Eastern EU countries with about 6x more enrollment velocity and a 20% higher average performance score. With these insights, the CRO won the rescue program and is using the findings to inform its post-rescue mitigation plan.
Related products
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Trialtrove
Discover the ultimate clinical trial benchmarking tool
Real-World Data Solutions
Take a patient-centric view of your clinical trial planning and execution by tapping into a diverse, tokenized real world dataset covering over 300 million US lives.
NOV 19, 2025
Webinar
Patient Engagement & Recruitment
Boost Participant Recruitment with Precision Feasibility and RWD
Traditional site selection based on past performance isn’t enough. Sponsors need data-driven strategies to optimize global trial planning. Learn how independent insights and precision feasibility unlock better site enablement and patient recruitment.
